Hunt, Barnaby

Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK

Bain, S. C., Bekker Hansen, B., Hunt, B., Chubb, B., & Valentine, W. J. (2020) · Journal of Medical Economics

Diabetes Treatment and ManagementHealth Systems, Economic Evaluations, Quality of Life

Cited by 53

Evaluation of the long-term cost-effectiveness of once-weekly semaglutide versus dulaglutide for treatment of type 2 diabetes mellitus in the UK

Viljoen, A., Hoxer, C. S., Johansen, P., Malkin, S., Hunt, B., & Bain, S. C. (2019) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementHealth Systems, Economic Evaluations, Quality of Life

Cited by 45

Long-term cost-effectiveness of two GLP-1 receptor agonists for the treatment of type 2 diabetes mellitus in the Italian setting: Liraglutide versus lixisenatide

Hunt, B., Kragh, N., McConnachie, C. C., Valentine, W. J., Rossi, M. C., & Montagnoli, R. (2017) · Clinical Therapeutics

Diabetes Treatment and ManagementHealth Systems, Economic Evaluations, Quality of Life

Cited by 24

Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States

Wilkinson, L., Hunt, B., Johansen, P., Iyer, N. N., Dang-Tan, T., & Pollock, R. F. (2018) · Diabetes Therapy

Diabetes Treatment and ManagementHealth Systems, Economic Evaluations, Quality of Life

Cited by 18

Improving quality of care in people with Type 2 diabetes through the Associazione Medici Diabetologi‐annals initiative: a long‐term cost‐effectiveness analysis

Giorda, C. B., Nicolucci, A., Pellegrini, F., Kristiansen, C. K., Hunt, B., Valentine, W. J., & Vespasiani, G. (2014) · Diabetic Medicine

Health Systems, Economic Evaluations, Quality of LifeDiabetes Treatment and Management

Cited by 17